To view this email as a web page, click here

February 08, 2017

Subscribe

Our Team

Contact Us

FierceBiotech Logo

 

Today's Rundown

  1. Merrimack employee accused of leaking clinical trial data

  2. Chan-Zuckerberg health project injects $50M into new Biohub scientists

  3. Lundbeck calls time on Alzheimer’s drug after more failures

  4. Chinese I-O biotech Abbisko raises $28M in first-round funding

  5. Intensix raises $8.3M for machine-learning tech to head off ICU complications

Featured Story

Merrimack employee accused of leaking clinical trial data

Authorities have arrested Merrimack Pharmaceuticals’ director of statistical programming. The case alleges that Songjiang Wang leaked positive results for three different Merrimack clinical trials to an employee of Akebia Therapeutics, who, in turn, shared tips about a study run by his company, Reuters reports.


Top Stories

Chan-Zuckerberg health project injects $50M into new Biohub scientists

Billionaire husband-and-wife team Priscilla Chan and Facebook founder Mark Zuckerberg have stumped up around $50 million to fund 47 "CZ Biohub" investigators from across U.S. academia.

Lundbeck calls time on Alzheimer’s drug after more failures

Lundbeck is calling time on development of Alzheimer’s candidate idalopirdine after it chalked up a clean sweep of failures in phase 3. The Danish drugmaker made the decision after learning the 5-HT6 agonist, which failed its first phase 3 in September, had come up short in its second and third late-stage studies.

Chinese I-O biotech Abbisko raises $28M in first-round funding

Shanghai-based startup Abbisko Therapeutics has raised $28 million in a Series A financing that will be used to advance its cancer immunotherapies into clinical trials.

Intensix raises $8.3M for machine-learning tech to head off ICU complications

Intensix, which is harnessing machine learning in the ICU, reeled in an $8.3 million Series A. The funds are pegged for the expansion of its sales and marketing ops in North America as well as further development of its predictive analytics platform.

News of Note

Sanofi said in its financials this morning that it plans for a resubmission of its FDA-delayed arthritis candidate sarilumab in the first quarter. Release

The FDA has given its fast-track tag to Angionetics' one-time gene therapy in patients with coronary heart disease. Statement

Takeda has handed over $1 million as a gift to the Koch Institute for Integrative Cancer Research at MIT to help it with immuno-oncology research. Release

Resources

[Whitepaper] Expert Advice: Designing Systems for Global Content Processes

Learn over a dozen best practices for deploying a global content system. Read Whitepaper.

[Whitepaper] Delayed and Confusing IDMP Requirements Demand Two-Part Strategy

Gartner provides insightful research on preparing for IDMP compliance. Read Whitepaper.

[Whitepaper] Transformation Initiatives Underway for Regulatory Information Management

Learn How to Create a Unified RIM Environment for IDMP. Find out.

[Whitepaper] Considering an eTMF Solution? Industry Research Reveals the Top Benefits

The largest survey of TMF owners reveals drivers and trends in improving inspection readiness and shortening trial time.

[Whitepaper] The Trailblazer's Guide to Apps

Learn how the healthcare and life science industry is using agile application development to drive innovation and accelerate their business with the Salesforce Platform.

[Whitepaper] Ensuring the Greatest Return From Your Poorly Soluble Molecule

Can you avoid a risky trial-and-error approach to find the right path for your poorly soluble molecule by utilizing a CDMO? Download this complimentary Whitepaper to learn more!

Events

.